Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components

Patent No. EP3011034 (titled "Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components") was filed by Massachusetts Institute OF Technology on Jun 11, 2014. The application was issued on Aug 7, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREMay 7, 2020WILDING

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3011034

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP14736206A
Filing Date
Jun 11, 2014
Status
Revoked
Jul 30, 2021
Publication Date
Aug 7, 2019